PSTV

#4002
PLUS THERAPEUTICS, Inc. - Common Stock
5.8 2 USD
-9.49%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
5.82
5.82
Range Annuel
0.13
8.00
Changement quotidien
-9.49%
Changement Mensuel
+4.49%
Evolution sur 6 mois
+854.10%
Changement Annuel
+1906.90%
Clôture Précédente
6.4 3
Open
5.8 2
Low
5.8 2
High
5.8 2
Volume
22
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

PLUS THERAPEUTICS, Inc. - Common Stock

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Nouvelles